Company Quick10K Filing
Ionis Pharmaceuticals
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-05
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-04
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-03-03
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-06
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-01
8-K 2020-06-04
8-K 2020-05-06
8-K 2020-02-26
8-K 2020-01-15
8-K 2020-01-09
8-K 2019-12-19
8-K 2019-12-11
8-K 2019-12-11
8-K 2019-11-06
8-K 2019-09-27
8-K 2019-08-07
8-K 2019-06-10
8-K 2019-06-06
8-K 2019-05-09
8-K 2019-03-22
8-K 2019-02-27
8-K 2018-12-21
8-K 2018-11-06
8-K 2018-10-18
8-K 2018-10-10
8-K 2018-09-25
8-K 2018-08-27
8-K 2018-08-07
8-K 2018-06-19
8-K 2018-05-30
8-K 2018-05-04
8-K 2018-04-20
8-K 2018-03-15
8-K 2018-02-27
8-K 2018-01-16

Ionis Pharmaceuticals Financials

IONS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458
Elanco Animal Health (ELAN) 9,964 52% 30.6 1% 8,824 3,336 3,083 1,611 94 393 12,004
Alnylam Pharmaceuticals (ALNY) 8,913 80% -9.7 -32% 2,542 935 169 135 -821 -820 7,987
Ionis Pharmaceuticals (IONS) 8,784 76% 17.4 15% 2,895 1,397 821 626 436 491 8,536
Bausch (BHC) 7,760 0% 25.3 -1% 31,667 29,107 8,498 0 -266 1,216 30,774
Jazz Pharmaceuticals (JAZZ) 7,549 21% 11.2 11% 5,528 2,473 2,056 441 609 762 8,530
Perrigo (PRGO) 7,421 37% 17.9 2% 11,311 5,552 4,710 1,735 247 580 10,388
Sage Therapeutics (SAGE) 7,414 82% -10.7 -56% 1,204 123 5 4 -670 -670 7,152
Catalent (CTLT) 7,405 32% 23.8 2% 6,120 3,864 2,631 834 152 421 10,021
Teva (TEVA) 7,142 43% -10.6 -7% 57,246 42,322 17,455 7,550 -3,961 -2,814 29,713
Dr Reddys Laboratories (RDY) 6,726 0% 225,427 85,230 0 0 0 0 6,714
Acadia Pharmaceuticals (ACAD) 6,020 96% -23.0 -32% 766 76 300 289 -248 -245 5,630
Sarepta Therapeutics (SRPT) 5,588 0% -7.9 -36% 1,702 707 365 0 -620 -576 4,529
Amarinuk (AMRN) 5,417 61% -75.7 -7% 867 271 364 221 -63 -63 4,799
Horizon Pharma (HZNP) 5,349 71% 26.5 2% 3,721 2,166 1,292 915 68 222 5,880
Array Biopharma (ARRY) 5,260 92% -43.6 -22% 567 265 240 221 -126 -114 4,960
Galapagos (GLPG) 5,015 0% 1,439 225 0 0 0 0 5,015
Loxo Oncology (LOXO) 4,868 0% 697.4 1% 659 280 124 0 7 7 4,732
Taro Pharmaceutical Industries (TARO) 4,157 0% 2,135 224 0 0 0 0 3,589

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4610070868555655686851241082972561601629473143148119127129931138485114133159130228805480279376273248
Accounts Receivable
Inventory89111919
PP&E36363638889897959493919088878687868889899089909091919395100117122123128132132134135149
Assets6065765505065305064854714724865465537898828478358187949569559769889568768118449121,0841,0911,2531,3221,3002,2472,2482,6682,8362,8782,895
Accounts Payable537537856510599111013161816111928191816212313242514131429131613
Long-Term Debt646555179
Liabilities3443223062783173193133203183153633523884804694614514496986806767437557187007048138828758559039121,4301,4081,4811,4481,4211,397
Stockholders' Equity2622542451871711511541701832014014013783743673452582763002452011581111401002022163083313016967111,0481,2081,2691,336
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue242926212521322347122043382442286244856312049523738111160110104121172144118145192297164168
Cost of Revenue111
Gross Profit296162167
R&D393539343640473940374338434551
SG&A3333334333333354547789131110101814222746448369687560
Tax0-0000000-10000000-11000-003001-700031-7-15
Net Income-25-12-14-20-18-31-12-2731-1736-36-71-63-577263-11-13-1-40-532091-126
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-21-26-40-26-24-24-7-3-25-112366-14-32-34271-436536-37-76-3423-26123292013500-26108-27-13
Cash Investing76-75725-434-124-11-15-32-123-8525-32-24-5137-95-29283953-5721-169-150-5479-375-308-70-1111
Cash Financing-03-10-11-283491981739-12501210121-056761484545385935-13